CMS listed on the New York Stock Exchange in December 2009.

We received investments from the Carlyle Group, China International Capital Corporation Limited (CICC) and C.V. Starr & Co. Inc. through PE fundings.

We acquired Medstar for about £17 million (US$35 million) and Medstar was delisted from London AIM Market.

CMS was established. AMS was regrouped as part of CMS.

China Medstar, later acquired by us, was listed on the London Stock Exchange's AIM market.

We sponsored China's first domestically published medical textbook, Head Gamma Knife Therapeutics.

A third party, which we acquired later in 2009, installed China's first PET-CT in Xi'an.

A third party, which we acquired later in 2009, installed China's first MM50 intensity-modulated radiation therapy system in Xi'an.

We sponsored China's first domestically published book on gamma knife, Magic Gamma Knife.

We organized China's first International Gamma Knife Academic Seminar in Harbin.

We installed our first Body Gamma Knife system in Guangzhou.

We installed our first Linear Accelerator in Guangzhou.

AMS commenced operations.

Medstar commenced operations.

The predecessor of one of our subsidiaries installed our first Head Gamma Knife system and our first MRI scanner in Guangzhou.